)
NextPlat (NXPL) investor relations material
NextPlat Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved significant sequential growth in e-commerce and contracted healthcare services, driving consolidated gross margin to a record 40% and nearly eliminating net loss.
Net loss reduced by 87% year-over-year to $144,000, with adjusted profitability excluding a one-time $0.5 million professional fee expense.
Operates in two segments: e-Commerce (satellite communications) and Healthcare (pharmacy, analytics, 340B program).
Strategic acquisition near Pensacola and launch of a new healthcare e-commerce website are expected to further expand market reach and revenue streams.
Turnaround efforts and operational efficiencies focused on higher-margin 340B and government healthcare contracts.
Financial highlights
Q2 2026 net revenues were $11.9 million, up 21% sequentially but down 10% year-over-year due to industry reimbursement pressures.
Consolidated gross profit rose 63% year-over-year to $4.7 million, with gross margin expanding to 40% from 22% in Q2 2025.
Operating loss reduced by 93% to $127,000 from $1.8 million in Q2 2025; net loss was $144,000 or $0.05 per share, compared to $1.8 million or $0.69 per share a year ago.
Ended the quarter with $11.9 million in cash and $14.2 million in working capital.
Operating expenses were $4.8 million, up slightly due to a one-time professional fee; excluding this, expenses declined 8%.
Outlook and guidance
Expects continued sequential and year-over-year revenue growth in healthcare, driven by new contracts and the Pensacola acquisition.
Anticipates reaching and sustaining bottom-line profitability beginning in Q3 2026, barring transaction and integration costs.
Priorities include expanding contract-based healthcare, sustaining gross margins, disciplined expense management, and evaluating strategic acquisitions.
Management expects current liquidity and operational plans to support at least 12 months of operations.
Launch of a nationwide medication fulfillment website in Q3 2026 is anticipated to expand reach and support future growth.
- Record 40% gross margin and $54.3M revenue highlight a successful turnaround and global expansion.NXPL
Corporate presentation - Turnaround drives margin gains and nationwide healthcare expansion, supporting profitable growth.NXPL
Corporate presentation - All board nominees and proposals were approved by majority vote; results to be filed in Form 8-K.NXPL
AGM 2026 - Registering 2,097,011 shares for resale, with no proceeds to the company and significant dilution risk.NXPL
Registration filing - Turnaround delivers margin expansion, cost cuts, and nationwide healthcare growth.NXPL
Corporate presentation - Record 35% gross margin and reduced losses highlight progress in turnaround and growth.NXPL
Q1 2026 - Turnaround drives margin growth, nationwide expansion, and global e-commerce momentum.NXPL
Corporate presentation - Registering 2.65M shares for resale, with no proceeds to the company and ongoing net losses.NXPL
Registration filing - Shareholders will vote virtually on director elections, auditor ratification, and executive pay.NXPL
Proxy filing
Next NextPlat earnings date
Next NextPlat earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage